Skip to main content

Center for Breakthrough Medicines

King Of Prussia, United States

Center for Breakthrough Medicines is an innovative cell and gene therapy focusing on contract development and manufacturing organization.

$350.0M raised
Jan 2022
Corporate Round

Top Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Center for Breakthrough Medicines

How much funding has Center for Breakthrough Medicines raised?
Center for Breakthrough Medicines has raised $350.0M in total funding. The most recent round was Corporate Round. The last funding was announced in January 2022.
Who are Center for Breakthrough Medicines's investors?
Center for Breakthrough Medicines's investors include SK Holdings.
Where is Center for Breakthrough Medicines headquartered?
Center for Breakthrough Medicines is headquartered in King Of Prussia, United States.
What does Center for Breakthrough Medicines do?
Center for Breakthrough Medicines is an innovative cell and gene therapy focusing on contract development and manufacturing organization.
What stage is Center for Breakthrough Medicines at?
Center for Breakthrough Medicines is at the Corporate Round stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Center for Breakthrough Medicines — Funding & Investors." VCBacked, January 10, 2022, https://www.vcbacked.co/company/center-for-breakthrough-medicines. Accessed July 2, 2026.
APA
VCBacked. (2022). Center for Breakthrough Medicines — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/center-for-breakthrough-medicines
Wikipedia (cite web)
{{cite web |title=Center for Breakthrough Medicines — Funding & Investors |url=https://www.vcbacked.co/company/center-for-breakthrough-medicines |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .